aplastic anemia | Page 7 | Aplastic Anemia & MDS International Foundation

aplastic anemia

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

This is a phase II, open label, multi-center, intra-patient dose escalation study to characterize the pharmacokinetics after oral administration of

2019 Patient & Family Conference (Pittsburgh Area)

Conference materials from the 2019 Patient & Family Conference:  Pittsburgh area

Event Date: 
Sat, 09/21/2019 - 7:30am
Conference Event Type: 

Get involved with AAMDSIF!

There are many ways patients, families, caregivers, communities and friends can help support the Foundation in our search for a cure. Join us! 

Event Date: 
Tue, 12/31/2019 - 11:18pm
Community Event Type: 

Find Out More:

The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia

Author(s): 
Marsh JC, Risitano AM, Mufti GJ
Primary Author: 
Marsh JC
Journal Title: 
Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation
Original Publication Date: 
May 2019

Improved success of HLA-matched unrelated donor (MUD) hematopoietic stem cell transplantation (HCT) for severe

Bone Marrow Diseases: 

2019 Patient & Family Conference (Rockville, Maryland)

Thank you for attending the 2019 Patient & Family Conference in Rockville, Maryland. 

Event Date: 
Sat, 05/18/2019 - 7:30am
Conference Event Type: